SBI Healthcare Opportunities Fund vs Tata India Pharma & Healthcare Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹3989 Cr | ₹1310 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 31 Dec 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 32% | 26.49% |
| Expense Ratio | 1.94 | 2.14 |
| Manager | Pradeep Kesavan | Meeta Shetty |
| ISIN Code | INF200K01446 | INF277K016A9 |
| Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -3.99% | -5.62% |
| 6 Month | -7.96% | -7.64% |
| 1 Year | 1.93% | 1.29% |
| 3 Year | 22.44% | 20.33% |
| 5 Year | 15.67% | 14.17% |
SIP Return Analysis
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -5.95% | -6.87% |
| 1 Year | -8.23% | -8.62% |
| 3 Year | 13.06% | 11.19% |
| 5 Year | 16% | 13.84% |
Rolling Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 15.02% | 7.74% |
| 3 Year | 18.07% | 18.94% |
| 5 Year | 13.4% | 15.54% |
Risk Management
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.02% | 14.23% |
| Sharp | 1.19% | 0.98% |
| Beta | 0.81% | 0.92% |
| Alpha | 3.86% | 1.32% |
Fund Managers
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Pradeep Kesavan | Meeta Shetty |
| Total AUM | ₹434274 Cr | ₹17847 Cr |
| Funds Managed | 43 | 5 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 16.36 | 2.84 |
| Mid Cap | 26.66 | 40.02 |
| Small Cap | 30.64 | 37.23 |
| Large Cap | 26.34 | 19.92 |
Sector Allocation
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.4 | 1.31 |
| Basic Materials | 6.86 | 3.68 |
| Healthcare | 89.74 | 95 |
Top Comparisons
HDFC Flexi Cap Fund - Growth Plan
3Y Returns21.94%
Motilal Oswal Flexi Cap Fund Regular Plan-Growth Option
3Y Returns22.24%
Mirae Asset Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
Axis Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns17.39%
Invesco India Credit Risk Fund - Regular Plan - Growth
3Y Returns9.24%
Aditya Birla Sun Life Credit Risk Fund - Regular Plan - Growth
3Y Returns11.79%
LIC MF Equity Hybrid Fund-Growth
3Y Returns13.34%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns15.51%